Viewing Study NCT06459895



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06459895
Status: COMPLETED
Last Update Posted: 2024-06-14
First Post: 2024-06-10

Brief Title: Biochemical Role of Long Non-coding RNA MALAT 1 and Serum Tumor Necrosis Factor Alpha in Bronchial Asthma Patients
Sponsor: Sohag University
Organization: Sohag University

Study Overview

Official Title: Biochemical Role of Long Non-coding RNA MALAT 1 and Serum Tumor Necrosis Factor Alpha in Bronchial Asthma Patients
Status: COMPLETED
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Bronchial asthma affects more than a quarter of a billion people worldwide It is responsible for over 1000 deaths a day of which the majority are preventable Levy 2015

Asthma is a common heterogeneous disease characterized by chronic airway inflammation It is defined by the history of variable respiratory symptoms such as shortness of breath chest tightness wheezes and cough together with variable expiratory airflow limitation Airflow limitation may later become persistent GINA 2023

The diagnosis of asthma is based on the history of these characteristic symptoms and evidence of variable expiratory airflow limitation from bronchodilator reversibility testing or other tests GINA 2023
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None